Top-Paying Oncology Specialties Worldwide in 2025

Top-Paying

SIOG and OncoDaily Announce Strategic Partnership to Advance Global Geriatric Oncology

SIOG

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology

Razelle Kurzrock: Our Commentary and Implications for Future Precision Studies

Razelle Kurzrock

Applications are Open for IDEA Program with Special QI Mentorship Opportunity - ASCO

IDEA Program

Anirban Maitra: Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E mCRC

Anirban Maitra

Minhua Chu: Rui Therapeutics Completed a Series A Financing Exceeding RMB 200 Million

Minhua Chu, Rui Therapeutics

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

OncoCalendar

« All Events

  • This event has passed.

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference

November 15, 2024 • 12:00 AM - November 17, 2024 • 12:00 AM
ESH-EBMT-EHA-IPIG 3rd Translational Research Conference

The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024.

It will offer valuable insights for both clinical and non-clinical scientists, including M.D.s and Ph.D.s of all levels, who are interested in the biology, pathophysiology, diagnosis, and treatment of bone marrow failure syndromes (BMFS) and predisposition syndromes. The conference will address both acquired and inherited BMFS in adults and children, with a particular focus on emerging principles and innovative treatment strategies.

As is customary for ESH, the event will prioritize accessible interactions between young researchers and established experts, as well as between clinicians and basic scientists. Workshops with experts and poster walks will emphasize key topics and provide opportunities for in-depth discussion. The distinguished faculty will ensure a high standard of clinical, translational, and basic research is maintained throughout the conference.

For Registration Visit Here

Details

Start:
November 15, 2024 • 12:00 AM
End:
November 17, 2024 • 12:00 AM
Website:
https://www.esh.org/conference/esh-ebmt-eha-3rd-translational-research-conference-bone-marrow-failure-and-leukaemia-predisposition-syndromes/

Organizer

European School of Haematology
Phone
+ 33(0)1 57 27 67 39
Email
info(at)esh.org
View Organizer Website

Venue

Espace Saint-Martin
199 Bis r St Martin, 75003 Paris
Paris, 75001 Sweden + Google Map
Phone
+33 1 44 54 38 54
View Venue Website